# The Effect of Monthly Vitamin D Replacement on Bone Turnover Parameters and Inflammation Parameters in Hemodialysis Patients

## Authors

- Zelal Adibelli ([ORCID](https://orcid.org/0000-0001-7091-5204)) — Usak University, Faculty of Medicine, Department of Nephrology, Usak, Turkey
- Soycan Mizrak ([ORCID](https://orcid.org/0000-0001-8646-345X)) — Usak University, Faculty of Medicine, Department of Medical Biochemistry, Usak, Turkey

## Article information

- **Journal:** The Ulutas Medical Journal (Ulutas Med J), ISSN 2149-388X
- **Issue:** Volume 6, Issue 3 (2020), pages 125–130
- **Article type:** Original Article
- **Published online:** 2020-09-19
- **DOI:** [10.5455/umj.20200713054707](https://doi.org/10.5455/umj.20200713054707)
- **Licence:** [CC BY-NC 4.0](https://creativecommons.org/licenses/by-nc/4.0/)
- **Article page:** https://www.ulutasmedicaljournal.com/?mno=98451
- **PDF:** https://www.ulutasmedicaljournal.com/pdf/98451.pdf

## Abstract

Introduction: Vitamin D replacement is recommended for chronic kidney patients as vitamin D prevents the development of secondary hyperparathyroidism. However, the optimal vitamin D level or dosage is controversial. In this study, we investigated the basal vitamin D levels in patients undergoing hemodialysis, and effects of high dose vitamin D supplements on serum Vitamin D, parathormone (PTH), calcium (Ca), phosphorus (P), alkaline phosphatase (ALP), C-reactive protein (CRP), and albumin test levels. Materials and Methods: 61 patients who have been in the routine hemodialysis program for at least six months in Usak University Training and Research Hospital included in the study. The demographic characteristics of the patients, 25(OH) vitamin D, PTH, Ca, P, ALP, albumin, CRP levels collected from the patient records before and after three months of high dose vitamin D (150.000-300.000IU) replacement. The data obtained in this study analyzed with SPSS 21 package program. Results: 31 of the patients were female, 30 were male. The mean age of the patients was 63.39±13.76. Vitamin D level was insufficient or deficient in 95.2% of the patients. Only there was a statistically significant correlation between basal vitamin D levels and dialysis duration (p

## Keywords

Hemodialysis; vitamin D; bone turnover

## How to cite

Adibelli Z, Mizrak S. The Effect of Monthly Vitamin D Replacement on Bone Turnover Parameters and Inflammation Parameters in Hemodialysis Patients. Ulutas Med J. 2020;6(3):125-130. doi:10.5455/umj.20200713054707

## References

1. Holick MF, Krane SM, Potts JT. Calcium, phosphorus, and bone metabolism: Calcium-regulation hormones. In: Fauci AS, Braunwald E, Isselbacher KJ, et al (Eds). Harrison's principles of internal medicine. 14th ed. New York: McGraw-Hill; 1995:2214
2. Thacher TD, Clarke BL. Vitamin D insufficiency. Mayo Clin Proc 2011; 86(1):50-60 https://doi.org/10.4065/mcp.2010.0567
3. Gal-Moscovici A, Sprague SM: Role of Vitamin D deﬁciency in chronic kidney Disease. J Bone Miner Res 2007;22:91-94 https://doi.org/10.1359/jbmr.07s203
4. Michael F. Holick: Vitamin D for Health and in chronic kidney disease.Seminars in Dialysis - vol 18, No 4, 2005 https://doi.org/10.1111/j.1525-139x.2005.18402.x
5. Yin K, Agrawal DK. Vitamin D and inflammatory diseases. J Inflamm Res. 2014;7:69–87 https://doi.org/10.2147/jir.s63898
6. Taskapan H, Wei M, Oreopoulos DG (2006)25(OH) Vitamin D(3) in patients with chronic kidney disease and those on dialysis: rediscovering its importance. Int Urol Nephrol 38(2):323–329 https://doi.org/10.1007/s11255-006-0081-7
7. Hossein-nezhad A, Holick MF. Vitamin D for health: A Global perspective. Mayo Clin Proc 2013 July; 88(7):720– 55 https://doi.org/10.1016/j.mayocp.2013.05.011
8. Türkiye Endokrinoloji ve Metabolizma Derneği. Osteoporoz ve Metabolik Kemik Hastalıkları Tanı ve Tedavi Kılavuzu 2018: 119-27
9. Jean G, Souberbielle JC, Chazot C. Vitamin D in chronic kidney disease and dialysis patients. Nutrients 2017;9(4):1-15 https://doi.org/10.3390/nu9040328
10. Keung L, Perwad F. Vitamin D and kidney disease. Bone Rep 2018;9:93-100 https://doi.org/10.1016/j.bonr.2018.07.002
11. Eknoyan G, Lameire M, Kasiske B. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKD-MBD). Kidney Int Suppl 2017;7:1–59 https://doi.org/10.1016/j.kisu.2017.10.001
12. Eknoyan G,Levin NM: Bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003;42:1-201 https://doi.org/10.1016/s0272-6386(03)00905-3
13. Gonzales EA,Sachdeva A,Oliver DA et al. Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study. Am J Nephrol 2004;24: 503-510
14. Tokmak F, Quack I, Schieren G, Sellin L, Rattensperger D, HollandLetz T, Weiner SM, Rump LC: High-dose chole calciferol to correct vitamin D deﬁciency in haemodialysis patients. Nephrol Dial Transplant 2008;23:4016-4020 https://doi.org/10.1093/ndt/gfn367
15. Tentori F,Stidley C,Brown R et al:Survival does not differ among incident hemodialysis patients treated with the different vitamin D analogs,in vol (F-PO940), American Society of Nephrology Meeting, 2003
